151 related articles for article (PubMed ID: 21513843)
21. Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin.
Bougnoux ME; Dannaoui E; Accoceberry I; Angoulvant A; Bailly E; Botterel F; Chevrier S; Chouaki T; Cornet M; Dalle F; Datry A; Dupuis A; Fekkar A; Gangneux JP; Guitard J; Hennequin C; Le Govic Y; Le Pape P; Maubon D; Ranque S; Sautour M; Sendid B; Chandenier J
Antimicrob Agents Chemother; 2016 Aug; 60(8):5088-91. PubMed ID: 27297480
[TBL] [Abstract][Full Text] [Related]
22. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Jones RN; Turnidge J; Diekema DJ
J Clin Microbiol; 2010 Jan; 48(1):52-6. PubMed ID: 19923478
[TBL] [Abstract][Full Text] [Related]
23. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).
Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):45-50. PubMed ID: 21146713
[TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents.
Alexander BD; Byrne TC; Smith KL; Hanson KE; Anstrom KJ; Perfect JR; Reller LB
J Clin Microbiol; 2007 Mar; 45(3):698-706. PubMed ID: 17202279
[TBL] [Abstract][Full Text] [Related]
25. Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.
Espinel-Ingroff A; Alvarez-Fernandez M; Cantón E; Carver PL; Chen SC; Eschenauer G; Getsinger DL; Gonzalez GM; Govender NP; Grancini A; Hanson KE; Kidd SE; Klinker K; Kubin CJ; Kus JV; Lockhart SR; Meletiadis J; Morris AJ; Pelaez T; Quindós G; Rodriguez-Iglesias M; Sánchez-Reus F; Shoham S; Wengenack NL; Borrell Solé N; Echeverria J; Esperalba J; Gómez-G de la Pedrosa E; García García I; Linares MJ; Marco F; Merino P; Pemán J; Pérez Del Molino L; Roselló Mayans E; Rubio Calvo C; Ruiz Pérez de Pipaon M; Yagüe G; Garcia-Effron G; Guinea J; Perlin DS; Sanguinetti M; Shields R; Turnidge J
Antimicrob Agents Chemother; 2015 Nov; 59(11):6725-32. PubMed ID: 26282428
[TBL] [Abstract][Full Text] [Related]
26. Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp.
Peterson JF; Pfaller MA; Diekema DJ; Rinaldi MG; Riebe KM; Ledeboer NA
J Clin Microbiol; 2011 May; 49(5):1765-71. PubMed ID: 21430096
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of CLSI M44-A2 disk diffusion and associated breakpoint testing of caspofungin and micafungin using a well-characterized panel of wild-type and fks hot spot mutant Candida isolates.
Arendrup MC; Park S; Brown S; Pfaller M; Perlin DS
Antimicrob Agents Chemother; 2011 May; 55(5):1891-5. PubMed ID: 21357293
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
29. Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.
Arendrup MC; Rodriguez-Tudela JL; Park S; Garcia-Effron G; Delmas G; Cuenca-Estrella M; Gomez-Lopez A; Perlin DS
Antimicrob Agents Chemother; 2011 Apr; 55(4):1580-7. PubMed ID: 21245440
[TBL] [Abstract][Full Text] [Related]
30. Determination of Echinocandin MICs for Candida species in less than 8 hours: comparison of the rapid susceptibility assay with the Clinical and Laboratory Standards Institute's broth microdilution assay.
Hazen KC; Dirks D; Masuoka J
J Clin Microbiol; 2009 Dec; 47(12):4043-8. PubMed ID: 19846655
[TBL] [Abstract][Full Text] [Related]
31. Antifungal susceptibility testing of micafungin against Candida glabrata isolates.
Oliveira ER; Fothergill A; Kirkpatrick WR; Patterson TF; Redding SW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):457-9. PubMed ID: 18329581
[TBL] [Abstract][Full Text] [Related]
32. Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin.
Marcos-Zambrano LJ; Escribano P; Rueda C; Zaragoza Ó; Bouza E; Guinea J
Antimicrob Agents Chemother; 2013 Nov; 57(11):5767-70. PubMed ID: 23979756
[TBL] [Abstract][Full Text] [Related]
33. Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.
Eschenauer GA; Nguyen MH; Shoham S; Vazquez JA; Morris AJ; Pasculle WA; Kubin CJ; Klinker KP; Carver PL; Hanson KE; Chen S; Lam SW; Potoski BA; Clarke LG; Shields RK; Clancy CJ
Antimicrob Agents Chemother; 2014; 58(4):1897-906. PubMed ID: 24395235
[TBL] [Abstract][Full Text] [Related]
34. Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Morishige H; Mano Y; Oguri T; Furuya N
Jpn J Antibiot; 2012 Oct; 65(5):335-47. PubMed ID: 23383435
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp.
Vale-Silva LA; Pinto P; Lopes V; Ramos H; Pinto E
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):941-6. PubMed ID: 21909651
[TBL] [Abstract][Full Text] [Related]
36. Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria.
Pfaller MA; Messer SA; Diekema DJ; Jones RN; Castanheira M
J Clin Microbiol; 2014 Jan; 52(1):108-14. PubMed ID: 24153129
[TBL] [Abstract][Full Text] [Related]
37. Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2006 Oct; 44(10):3533-8. PubMed ID: 17021079
[TBL] [Abstract][Full Text] [Related]
38. Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.
Arendrup MC; Prakash A; Meletiadis J; Sharma C; Chowdhary A
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416539
[No Abstract] [Full Text] [Related]
39. Resistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture Samples.
Bordallo-Cardona MÁ; Marcos-Zambrano LJ; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29712651
[TBL] [Abstract][Full Text] [Related]
40. Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
Cretella D; Barber KE; King ST; Stover KR
J Med Microbiol; 2016 Dec; 65(12):1445-1451. PubMed ID: 27902377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
